Skip to main content
. 2021 Jun 30;33(3):364–378. doi: 10.21147/j.issn.1000-9604.2021.03.08

Figure 2.

Figure 2

Associations between loads of HCC somatic mutation/neoantigen and patients’ clinical characteristics. (A−D) Kaplan-Meier curves of OS and RFS for patients stratified by overall mutation load (A), overall neoantigen load (B), somatic mutation load (C), somatic mutation-derived neoantigen load (D); (E) Column plot showing the ORs and 95% confidence intervals of the clinical parameters between patients with higher or lower somatic mutation/neoantigen load. The ORs and P values were calculated by χ2 test. HCC, hepatocellular carcinoma; OS, overall survival; RFS, recurrence-free survival; OR, odds ratio.